Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'CYTOTOXIC T-LYMPHOCYTE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 609 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Huarte, E; Sarobe, P; Lasarte, JJ; Brem, G; Weiss, EH; Prieto, J; Borras-Cuesta, F
      Identification of HLA-B27-restricted cytotoxic T lymphocyte epitope from carcinoembryonic antigen

      INTERNATIONAL JOURNAL OF CANCER
    2. Nguyen, CL; Bui, JT; Demcheva, M; Vournakis, JN; Cole, DJ; Gillanders, WE
      Sustained release of granulocyte-macrophage colony-stimulating factor froma modular peptide-based cancer vaccine alters vaccine microenvironment andenhances the antigen-specific T-cell response

      JOURNAL OF IMMUNOTHERAPY
    3. Maruyama, K; Akiyama, Y; Nara-Ashizawa, N; Hojo, T; Cheng, JY; Mizuguchi, H; Hayakawa, T; Yamaguchi, K
      Adenovirus-mediated MUC1 gene transduction into human blood-derived dendritic cells

      JOURNAL OF IMMUNOTHERAPY
    4. Huang, DR; Zhou, YH; Hoffman, GS
      Pathogenesis: immunogenetic factors

      BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
    5. Man, S; Fiander, A
      Immunology of human papillomavirus infection in lower genital tract neoplasia

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    6. Stern, PL; Faulkner, R; Veranes, EC; Davidson, EJ
      The role of human papillomavirus vaccines in cervical neoplasia

      BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY
    7. Imami, N; Hardy, G; Gotch, F
      Development of immunotherapeutic strategies for HIV-1

      EXPERT OPINION ON BIOLOGICAL THERAPY
    8. Sun, MY; Bowness, P
      MHC class I multimers

      ARTHRITIS RESEARCH
    9. Schirmbeck, R; Reimann, J
      Revealing the potential of DNA-based vaccination: Lessons learned from thehepatitis B virus surface antigen

      BIOLOGICAL CHEMISTRY
    10. Beck, A; Bussat, MC; Klinguer-Hamour, C; Goetsch, L; Aubry, JP; Champion, T; Julien, E; Haeuw, JF; Bonnefoy, JY; Corvaia, N
      Stability and CTL activity of N-terminal glutamic acid containing peptides

      JOURNAL OF PEPTIDE RESEARCH
    11. Leitner, WW; Hammerl, P; Thalhamer, J
      Nucleic acid for the treatment of cancer: Genetic vaccines and DNA adjuvants

      CURRENT PHARMACEUTICAL DESIGN
    12. De Groot, AS; Saint-Aubin, C; Bosma, A; Sbai, H; Rayner, J; Martin, W
      Rapid determination of HLA B*07 ligands from the West Nile Virus NY99 genome

      EMERGING INFECTIOUS DISEASES
    13. Altfeld, M; Walker, BD
      Less is more? STI in acute and chronic HIV-1 infection

      NATURE MEDICINE
    14. Gerard, CM; Baudson, N; Kraemer, K; Ledent, C; Pardoll, D; Bruck, C
      Recombinant human papillomavirus type 16 E7 protein as a model antigen to study the vaccine potential in control and E7 transgenic mice

      CLINICAL CANCER RESEARCH
    15. Yutani, S; Shichijo, S; Inoue, Y; Kawagoe, N; Okuda, K; Kurohiji, T; Tanaka, M; Sata, M; Itoh, K
      Expression of the SART1 tumor-rejection antigen in hepatocellular carcinomas

      ONCOLOGY REPORTS
    16. Jung, S; Chung, YK; Chang, SH; Kim, J; Kim, HR; Jang, HS; Lee, JC; Chung, GH; Jang, YS
      DNA-mediated immunization of glycoprotein 350 of Epstein-Barr virus induces the effective humoral and cellular immune responses against the antigen

      MOLECULES AND CELLS
    17. Zhou, HC; Xu, DZ; Wang, XP; Zhang, JX; Huang, Y; Yan, YP; Zhu, Y; Jin, BQ
      Identification of the epitopes on HCV core protein recognized by HLA-A2 restricted cytotoxic T lymphocytes

      WORLD JOURNAL OF GASTROENTEROLOGY
    18. Willemsen, RA; Debets, R; Hart, E; Hoogenboom, HR; Bolhuis, RLH; Chames, P
      A phage display selected Fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes

      GENE THERAPY
    19. Chen, CH; Wang, TL; Ji, H; Hung, CF; Pardoll, DM; Cheng, WF; Ling, M; Wu, TC
      Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene

      GENE THERAPY
    20. Pupa, SM; Invernizzi, AM; Forti, S; Di Carlo, E; Musiani, P; Nanni, P; Lollini, PL; Meazza, R; Ferrini, S; Menard, S
      Prevention of spontaneous neu-expressing mammary tumor development in micetransgenic for rat proto-neu by DNA vaccination

      GENE THERAPY
    21. Wodarz, D; Hall, SE; Usuku, K; Osame, M; Ogg, GS; McMichael, AJ; Nowak, MA; Bangham, CRM
      Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1

      PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    22. Wodarz, D
      Cytotoxic T-lymphocyte memory, virus clearance and antigenic heterogeneity

      PROCEEDINGS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    23. Moss, DJ; Burrows, SR; Silins, SL; Misko, I; Khanna, R
      The immunology of Epstein-Barr virus infection

      PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    24. Ahlers, JD; Belyakov, IM; Matsui, S; Berzofsky, JA
      Mechanisms of cytokine synergy essential for vaccine protection against viral challenge

      INTERNATIONAL IMMUNOLOGY
    25. Buseyne, F; Riviere, Y
      The flexibility of the TCR allows recognition of a large set of naturally occurring epitope variants by HIV-specific cytotoxic T lymphocytes

      INTERNATIONAL IMMUNOLOGY
    26. Chan, VSF; Cohen, ES; Weissensteiner, T; Cheah, KSE; Bodmer, HC
      Chondrocyte antigen expression, immune response and susceptibility to arthritis

      INTERNATIONAL IMMUNOLOGY
    27. Lohwasser, S; Kubota, A; Salcedo, M; Lian, RH; Takei, F
      The non-classical MHC class I molecule Qa-1(b) inhibits classical MHC class I-restricted cytotoxicity of cytotoxic T lymphocytes

      INTERNATIONAL IMMUNOLOGY
    28. Stanciu, LA; Roberts, K; Lau, LCK; Coyle, AJ; Johnston, SL
      Induction of type 2 activity in adult human CD8(+) T cells by repeated stimulation and IL-4

      INTERNATIONAL IMMUNOLOGY
    29. Monzavi-Karbassi, B; Cunto-Amesty, G; Luo, P; Shamloo, S; Blaszcyk-Thurin, M; Kieber-Emmons, T
      Immunization with a carbohydrate mimicking peptide augments tumor-specificcellular responses

      INTERNATIONAL IMMUNOLOGY
    30. Lawson, TM; Man, S; Wang, ECY; Williams, S; Amos, N; Gillespie, GM; Moss, PA; Borysiewicz, LK
      Functional differences between influenza A-specific cytotoxic T lymphocyteclones expressing dominant and subdominant TCR

      INTERNATIONAL IMMUNOLOGY
    31. Takahashi, M; Nakagawa, Y; Berzofsky, JA; Takahashi, H
      Counter-regulation of cytolytic activity and cytokine production in HIV-1-specific murine CD8(+) cytotoxic T lymphocytes by free antigenic peptide

      INTERNATIONAL IMMUNOLOGY
    32. Noguchi, M; Imaizumi, K; Kawabe, T; Wakayama, H; Horio, Y; Sekido, Y; Hara, T; Hashimoto, N; Takahashi, M; Shimokata, K; Hasegawa, Y
      Induction of antitumor immunity by transduction of CD40 ligand gene and interferon-gamma gene into lung cancer

      CANCER GENE THERAPY
    33. Takahashi, S; Yotnda, P; Roosseau, RF; Mei, ZY; Smith, S; Rill, D; Younes, A; Brenner, MK
      Transgenic expression of CD40L and interleukin-2 induces an autologous antitumor immune response in patients with non-Hodgkin's lymphoma

      CANCER GENE THERAPY
    34. Topakas, GN; Karchilaki, IN; Cacoullos, NT; Stavropoulos-Giokas, C
      Cell mediated cytotoxicity assessment by relative changes in viable targetabsolute counts

      IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
    35. Chaston, TB; Lidbury, BA
      Genetic 'budget' of viruses and the cost to the infected host: A theory onthe relationship between the genetic capacity of viruses, immune evasion, persistence and disease

      IMMUNOLOGY AND CELL BIOLOGY
    36. Ito, A; Kanto, T; Kuzushita, N; Tatsumi, T; Sugimoto, Y; Miyagi, T; Takehara, T; Katayama, K; Mochizuki, K; Hiramatsu, N; Kasahara, A; Yoshiya, I; Sasaki, Y; Hori, M; Hayashi, N
      Generation of hepatitis C virus-specific cytotoxic T lymphocytes from healthy individuals with peptide-pulsed dendritic cells

      JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
    37. Phu, T; Haeryfar, SMM; Musgrave, BL; Hoskin, DW
      Phosphatidylinositol 3-kinase inhibitors prevent mouse cytotoxic T-cell development in vitro

      JOURNAL OF LEUKOCYTE BIOLOGY
    38. Chambers, CA; Kuhns, MS; Egen, JG; Allison, JP
      CTLA-4-mediated inhibition in regulation of T cell responses: Mechanisms and manipulation in tumor immunotherapy

      ANNUAL REVIEW OF IMMUNOLOGY
    39. Takayanagi, T; Ohuchi, A
      A mathematical analysis of the interactions between immunogenic tumor cells and cytotoxic T lymphocytes

      MICROBIOLOGY AND IMMUNOLOGY
    40. Silva, CL; Bonato, VLD; Lima, KM; Coelho-Castelo, AAM; Faccioli, LH; Sartori, A; De Souza, AO; Leao, SC
      Cytotoxic T cells and mycobacteria

      FEMS MICROBIOLOGY LETTERS
    41. Aoki, H; Mizuno, M; Natsume, A; Tsugawa, T; Tsujimura, K; Takahashi, T; Yoshida, J
      Dendritic cells pulsed with tumor extract-cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    42. Michel, ML; Loirat, D
      DNA vaccines for prophylactic or therapeutic immunization against hepatitis B

      INTERVIROLOGY
    43. Afford, SC; Young, LS
      Gene therapy for hepatocellular carcinoma - Teaching old dogs new tricks

      HEPATOLOGY
    44. Kotlan, B; Fulop, V; Padanyi, A; Szigetvari, I; Reti, M; Gyodi, E; Feher, E; Petranyi, G
      High anti-paternal cytotoxic T-lymphocyte precursor frequencies in women with unexplained recurrent spontaneous abortions

      HUMAN REPRODUCTION
    45. Le, TTT; Drane, D; Malliaros, J; Cox, JC; Rothel, L; Pearse, M; Woodberry, T; Gardner, J; Suhrbier, A
      Cytotoxic T cell polyepitope vaccines delivered by ISCOMs

      VACCINE
    46. Rothman, AL; Kanesa-thasan, N; West, K; Janus, J; Saluzzo, JF; Ennis, FA
      Induction of T lymphocyte responses to dengue virus by a candidate tetravalent live attenuated dengue virus vaccine

      VACCINE
    47. Ishioka, GY; Fikes, J; Qin, MS; Gianfrani, C; Chesnut, RW; Kahn, LE; Streeter, PR; Woulfe, SL; Sette, A
      Dendritic cells generated in vivo by a chimeric hematopoietic growth factor, progenipoietin-4, demonstrate potent immunological function

      VACCINE
    48. Wan, Y; Wu, YZ; Bian, J; Wang, XZ; Zhou, W; Jia, ZC; Tan, Y; Zhou, L
      Induction of hepatitis B virus-specific cytotoxic T lymphocytes response in vivo by filamentous phage display vaccine

      VACCINE
    49. Pietersz, GA; Li, WJ; Apostolopoulos, V
      A 16-mer peptide (RQIKIWFQNRRMKWKK) from antennapedia preferentially targets the Class I pathway

      VACCINE
    50. van Tienhoven, EAE; ten Brink, CTB; van Bergen, J; Koning, F; van Eden, W; Broeren, CPM
      Induction of antigen specific CD4+T cell responses by invariant chain based DNA vaccines

      VACCINE
    51. Olszewska, W; Steward, MW
      Nasal delivery of epitope based vaccines

      ADVANCED DRUG DELIVERY REVIEWS
    52. Sobao, Y; Sugi, K; Tomiyama, H; Saito, S; Fujiyama, S; Morimoto, M; Hasuike, S; Tsubouchi, H; Tanaka, K; Takiguchi, M
      Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia

      JOURNAL OF HEPATOLOGY
    53. Cherpelis, S; Jin, X; Gettie, A; Ho, DD; Barnett, SW; Shrivastava, I; Stamatatos, L
      DNA-immunization with a V2 deleted HIV-1 envelope elicits protective antibodies in macaques

      IMMUNOLOGY LETTERS
    54. Imami, N; Hardy, G; Burton, C; Pires, A; Pido-Lopez, J; Moss, R; Gazzard, B; Gotch, F
      Immune responses and reconstitution in HIV-1 infected individuals: impact of anti-retroviral therapy, cytokines and therapeutic vaccination

      IMMUNOLOGY LETTERS
    55. Lee, YS; Yoon, SJ; Kwon, TK; Kim, YH; Woo, JH; Suh, MH; Suh, SI; Baek, WK; Kim, HJ; Ahn, SY; Choe, BK; Park, JW
      Immune response induced by immunization with Hepatitis B virus core DNA isolated from chronic active hepatitis patients

      IMMUNOLOGY LETTERS
    56. Maranon, C; Thomas, MC; Planelles, L; Lopez, MC
      The immunization of A2/K-b transgenic mice with the KMP11-HSP70 fusion protein induces CTL response against human cells expressing the T-cruzi KMP11 antigen: identification of A2-restricted epitopes

      MOLECULAR IMMUNOLOGY
    57. Tsuge, I; Morishima, T; Kimura, H; Kuzushima, K; Matsuoka, H
      Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NKcells in patients with severe chronic active EBV infection

      JOURNAL OF MEDICAL VIROLOGY
    58. Ciurea, A; Hunziker, L; Zinkernagel, RM; Hengartner, H
      Viral escape from the neutralizing antibody response: the lymphocytic choriomeningitis virus model

      IMMUNOGENETICS
    59. Longmate, J; York, J; La Rosa, C; Krishnan, R; Zhang, M; Senitzer, D; Diamond, DJ
      Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes

      IMMUNOGENETICS
    60. Oliveira-Ferreira, J; Daniel-Ribeiro, CT
      Protective CD8(+) T cell responses against the preerythrocytic stages of malaria parasites: an overview

      MEMORIAS DO INSTITUTO OSWALDO CRUZ
    61. Whitton, JL; Fujinami, RS
      Dna immunization and central nervous system viral infection

      ADVANCES IN VIRUS RESEARCH, VOL 56
    62. Kumar, A; Buch, S; Foresman, L; Bischofberger, N; Lifson, JD; Narayan, O
      Development of virus-specific immune responses in SHIVKU-infected macaquestreated with PMPA

      VIROLOGY
    63. Siegel, F; Lu, MJ; Roggendorf, M
      Coadministration of gamma interferon with DNA vaccine expressing woodchuckhepatitis virus (WHV) core antigen enhances the specific immune response and protects against WHV infection

      JOURNAL OF VIROLOGY
    64. Angel, JB; Parato, KG; Kumar, A; Kravcik, S; Badley, AD; Fex, C; Ashby, D; Sun, E; Cameron, DW
      Progressive human immunodeficiency virus-specific immune recovery with prolonged viral suppression

      JOURNAL OF INFECTIOUS DISEASES
    65. Blanchet, JS; Valmori, D; Dufau, I; Ayyoub, M; Nguyen, C; Guillaume, P; Monsarrat, B; Cerottini, JC; Romero, P; Gairin, JE
      A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: Implication for molecular anti-melanoma immunotherapy

      JOURNAL OF IMMUNOLOGY
    66. Nelson, DJ; Mukherjee, S; Bundell, C; Fisher, S; van Hagen, D; Robinson, B
      Tumor progression despite efficient tumor antigen cross-presentation and effective "arming" of tumor antigen-specific CTL

      JOURNAL OF IMMUNOLOGY
    67. Chowdhury, PS; Gallo, M; Pastan, I
      Generation of high titer antisera in rabbits by DNA immunization

      JOURNAL OF IMMUNOLOGICAL METHODS
    68. Johnson, TR; Fischer, JE; Graham, BS
      Construction and characterization of recombinant vaccinia viruses co-expressing a respiratory syncytial virus protein and a cytokine

      JOURNAL OF GENERAL VIROLOGY
    69. Kavanagh, DG; Gold, MC; Wagner, M; Koszinowski, UH; Hill, AB
      The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion

      JOURNAL OF EXPERIMENTAL MEDICINE
    70. Altfeld, M; Rosenberg, ES; Shankarappa, R; Mukherjee, JS; Hecht, FM; Eldridge, RL; Addo, MM; Poon, SH; Phillips, MN; Robbins, GK; Sax, PE; Boswell, S; Kahn, JO; Brander, C; Goulder, PJR; Levy, JA; Mullins, JI; Walker, BD
      Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection

      JOURNAL OF EXPERIMENTAL MEDICINE
    71. Kessler, JH; Beekman, NJ; Bres-Vloemans, SA; Verdijk, P; van Veelen, PA; Kloosterman-Joosten, AM; Vissers, DCJ; ten Bosch, GJA; Kester, MGD; Sijts, A; Drijfhout, JW; Ossendorp, F; Offringa, R; Melief, CJM
      Efficient identification of novel HLA-A*0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis

      JOURNAL OF EXPERIMENTAL MEDICINE
    72. Stinchcombe, JC; Barral, DC; Mules, EH; Booth, S; Hume, AN; Machesky, LM; Seabra, MC; Griffiths, GM
      Rab27a is required for regulated secretion in cytotoxic T lymphocytes

      JOURNAL OF CELL BIOLOGY
    73. Yamshchikov, GV; Barnd, DL; Eastham, S; Galavotti, H; Patterson, JW; Deacon, DH; Teates, D; Neese, P; Grosh, WW; Petroni, G; Engelhard, VH; Slingluff, GL
      Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients

      INTERNATIONAL JOURNAL OF CANCER
    74. Dorothee, G; Ameyar, M; Bettaieb, A; Vergnon, I; Echchakir, H; Bouziane, M; Chouaib, S; Mami-Chouaib, F
      Role of Fas and granule exocytosis pathways in tumor-infiltrating T lymphocyte-induced apoptosis of autologous human lung-carcinoma cells

      INTERNATIONAL JOURNAL OF CANCER
    75. Young, LS; Mautner, V
      The promise and potential hazards of adenovirus gene therapy

      GUT
    76. Ayyoub, M; Migliaccio, M; Guillaume, P; Lienard, D; Cerottini, JC; Romero, P; Levy, F; Speiser, DE; Valmori, D
      Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cellsfrom melanoma patients reveals inefficient antigen processing.

      EUROPEAN JOURNAL OF IMMUNOLOGY
    77. Benlalam, H; Labarriere, N; Linard, B; Derre, L; Diez, E; Pandolfino, MC; Bonneville, M; Jotereau, F
      Comprehensive analysis of the frequency of recognition of melanoma-associated antigen (MAA) by CD8 melanoma infiltrating lymphocytes (TIL): implications for immunotherapy

      EUROPEAN JOURNAL OF IMMUNOLOGY
    78. Dorrell, L; Willcox, BE; Jones, EY; Gillespie, G; Njai, H; Sabally, S; Jaye, A; DeGleria, K; Rostron, T; Lepin, E; McMichael, A; Whittle, H; Rowland-Jones, S
      Cytotoxic T lymphocytes recognize structurally diverse, clade-specific andcross-reactive peptides in human immunodeficiency virus type-1 gag throughHLA-B53

      EUROPEAN JOURNAL OF IMMUNOLOGY
    79. Palermo, B; Campanelli, R; Mantovani, S; Lantelme, E; Manganoni, AM; Carella, G; Da Prada, G; della Cuna, GR; Romagne, F; Gauthier, L; Necker, A; Giachino, C
      Diverse expansion potential and heterogeneous avidity in tumor-associated antigen-specific T lymphocytes from primary melanoma patients

      EUROPEAN JOURNAL OF IMMUNOLOGY
    80. Hung, CF; Hsu, KF; Cheng, WF; Chai, CY; He, LM; Ling, M; Wu, TC
      Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand

      CANCER RESEARCH
    81. Asselin-Paturel, C; Megherat, S; Vergnon, I; Echchakir, H; Dorothee, G; Blesson, S; Gay, F; Mami-Chouaib, F; Chouaib, S
      Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice - Relation with interleukin-10 induction

      CANCER
    82. Asselin-Paturel, C; Megherat, S; Vergnon, I; Echchakir, H; Dorothee, G; Blesson, S; Gay, F; Mami-Chouaib, F; Chouaib, S
      Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice - Relation with interleukin-10 induction

      CANCER CYTOPATHOLOGY
    83. Matsushita, M; Ikeda, H; Kizaki, M; Okamoto, S; Ogasawara, M; Ikeda, Y; Kawakami, Y
      Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia

      BRITISH JOURNAL OF HAEMATOLOGY
    84. Okada, N; Tsujino, M; Hagiwara, Y; Tada, A; Tamura, Y; Mori, K; Saito, T; Nakagawa, S; Mayumi, T; Fujita, T; Yamamoto, A
      Administration route-dependent vaccine efficiency of murine dendritic cells pulsed with antigens

      BRITISH JOURNAL OF CANCER
    85. Matsui, M; Machida, S; Tomiyama, H; Takiguchi, M; Akatsuka, T
      Introduction of tapasin gene restores surface expression of HLA class I molecules, but not antigen presentation of an HIV envelope peptide in a hepatoma cell line

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    86. Matsui, M; Ikeda, M; Akatsuka, T
      High expression of HLA-A2 on an oral squamous cell carcinoma with down-regulated transporter for antigen presentation

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    87. Dudley, ME; Ngo, LT; Westwood, J; Wunderlich, JR; Rosenberg, SA
      T-cell clones from melanoma patients immunized against an anchor-modified gp100 peptide display discordant effector phenotypes

      CANCER JOURNAL
    88. Moss, RB; Webb, E; Giermakowska, WK; Jensen, FC; Savary, JR; Wallace, MR; Carlo, DJ
      HIV-1-specific CD4 helper function in persons with chronic HIV-1 infectionon antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvant

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    89. Perricone, MA; Claussen, KA; Smith, KA; Kaplan, JM; Piraino, S; Shankara, S; Roberts, BL
      Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens

      MOLECULAR THERAPY
    90. Beecham, EJ; Ortiz-Pujols, S; Junghans, RP
      Dynamics of tumor cell killing by human T lymphocytes armed with an anti-carcinoembryonic antigen chimeric immunoglobulin T-cell receptor

      JOURNAL OF IMMUNOTHERAPY
    91. Carmon, L; Tzehoval, E; Tirosh, B; el-Shami, KM; Bar-Haim, E; Vadai, E; Feldman, M; Eisenbach, L
      Anti-tumor vaccination in heterozygous congenic F1 mice: Presentation of tumor-associated antigen by the two parental class I alleles

      JOURNAL OF IMMUNOTHERAPY
    92. Yang, JC; Perry-Lalley, D
      The envelope protein of an endogenous murine retrovirus is a tumor-associated T-cell antigen for multiple murine tumors

      JOURNAL OF IMMUNOTHERAPY
    93. Pinto, LA; Shearer, GM; Blazevic, V
      Immune-based approaches for control of HIV infection and viral-induced immunopathogenesis

      CLINICAL IMMUNOLOGY
    94. Moss, RB; Jensen, FC; Carlo, DJ
      Insights into HIV-specific immune function: Implications for therapy and prevention in the new millennium

      CLINICAL IMMUNOLOGY
    95. de Jong, A; Palefsky, JM; Stites, DP; Nakagawa, M
      Human immunodeficiency virus-positive individuals with oral hairy leukoplakia are able to mount cytotoxic T lymphocyte responses to Epstein-Barr virus

      ORAL DISEASES
    96. Jeffery, KJM; Bangham, CRM
      Do infectious diseases drive MHC diversity?

      MICROBES AND INFECTION
    97. Balian, A; Naveau, S; Zou, WP; Durand-Gasselin, I; Bouchet, L; Foussat, A; Galanaud, P; Chaput, JC; Emilie, D
      Pretreatment expression of the perforin gene by circulating CD8(+) T lymphocytes predicts biochemical response to interferon-alpha in patients with chronic hepatitis C

      EUROPEAN CYTOKINE NETWORK
    98. Ohno, S; Tachibana, M; Shibakita, M; Dhar, DK; Yoshimura, H; Kinugasa, S; Kubota, H; Masunaga, R; Nagasue, N
      Prognostic significance of Fas and Fas ligand system-associated apoptosis in gastric cancer

      ANNALS OF SURGICAL ONCOLOGY
    99. Ling, M; Kanayama, M; Roden, R; Wu, TC
      Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers

      JOURNAL OF BIOMEDICAL SCIENCE
    100. Kuriyama, S; Mitoro, A; Tsujinoue, H; Toyokawa, Y; Nakatani, T; Yoshiji, H; Tsujimoto, T; Okuda, H; Nagao, S; Fukui, H
      Electrochemotherapy can eradicate established colorectal carcinoma and leaves a systemic protective memory in mice

      INTERNATIONAL JOURNAL OF ONCOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/10/20 alle ore 20:22:55